Please ensure Javascript is enabled for purposes of website accessibility

After Hours: Rite Aid, Pier 1 Both Hit by Poor Q1s

By Eric Volkman - Updated Jun 26, 2019 at 8:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It wasn't a very happy results reporting day for the two struggling retailers.

Wednesday's post-stock market close news was, as in weeks past, dominated by quarterly results figures released late in the afternoon.

The stocks of two companies reporting, furniture retailer Pier 1 (PIRRQ) and pharmacy chain operator Rite Aid (RAD 1.11%), are seeing plenty of action... although probably not the kind of action they'd like to see.

Man sitting on couch with his leg wrapped and propped up, a crutch next to him.

Image source: Getty Images.

Rite Aid's Q1 loss

Rite Aid's stock could use a fresh bandage. It's getting hammered in the aftermarket; just now it's down 11% from its closing price today.

This follows the post-market release of its Q1 of fiscal 2020 results. During the quarter the company booked revenue of just under $5.4 billion, a slight decline from the same period last year. Same-store sales inched up by 1.4%.

Net loss, however, deepened to $99 million ($1.88 per share) from the year-ago figure of nearly $42 million ($0.79). The Q1 2020 result, though, was affected by over $43 million in what the company termed "pre-tax restructuring-related costs."

Regardless, that bottom-line deficit was wider than the average analyst estimate of $0.90 per share. At least revenue broadly met projections -- analysts had been expecting around $5.4 billion.

Rite Aid, the country's No. 3 pharmacy retail chain, has really fallen out of favor with investors since its failed merger with Walgreens Boots Alliance. On a fundamental level, it has struggled to compete with the ever-more powerful Walgreens and CVS Health.

Pier 1 sinks on results

Another retailer fighting to remain relevant is Pier 1 (PIRRQ), which also unveiled its Q1 2020 figures after market close.

For the period, Pier 1's total net sales fell by almost 16% to $314 million, on the back of same-store sales that suffered a 14% decline. The news wasn't much better on the bottom line, with net loss deepening to nearly $82 million ($19.97, although this is after a recent 1-for-20 reverse stock split) from the Q1 2019 shortfall of almost $26 million.

Those results were significantly worse than expected by analysts. On average, the prognosticators figured the company would absorb a per-share loss of $11.50 on net sales a bit north of $345 million.

Pier 1 is a poster-boy victim of the dreaded retail apocalypse. It hasn't adjusted well to the modern retail climate, and what's more, it operates in the always-competitive furniture and home furnishings segment.

Aftermarket investors are not in a tolerant mood with Pier 1 stock tonight. They're collectively trading the retailer's shares down by a steep 15% as of this writing.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pier 1 Imports, Inc. Stock Quote
Pier 1 Imports, Inc.
Rite Aid Corporation Stock Quote
Rite Aid Corporation
$9.09 (1.11%) $0.10

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.